OPKO files 8-K/A to update investor presentation after BioReference asset sale to LabCorp

OPKO HEALTH, INC.

Asset Purchase Agreement with LabCorp for BioReference Health, LLC signed March 27, 2024.
This amendment replaces the January investor presentation with a March 27, 2024 version.
Exhibit 2.1 (Asset Purchase Agreement) filed with schedules omitted; no deal value disclosed.
No financial or operational details from the updated presentation available in this filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.